Latest AstraZeneca Stories
DALLAS, January 6, 2015 /PRNewswire/ -- ReportsnReports.com adds "Global Isosorbide Market 2015-2019", a 58 pages Isosorbide business intelligence report, talking about
CAMBRIDGE, Mass., Jan.
ReportsnReports.com adds “Wheezing Global Clinical Trials Review, H2, 2014” to its store.
A law firm specializing in class action lawsuits, Carey Danis & Lowe supplies their expert analysis on the Syngenta GMO corn transfer order to a Kansas federal court for pretrial proceedings.
Farmers, exporters, and other Corn industry professionals are suing Biotech Giant Syngenta AG in multi-million dollar claims over China’s rejection of MIR 162 corn. Minneapolis,
ADDC researchers from US, Europe and Australia will receive access to AstraZeneca's compound library to aid in the discovery of new medicines BALTIMORE, Dec.
BASEL, Switzerland, December 22, 2014 /PRNewswire/ -- - Import approval granted for food and feed use - Agrisure Viptera(R) offers unrivalled control
Hundreds of Byetta lawsuits and other product liability claims involving incretin mimetic diabetes drugs are currently pending in the federal litigation underway in California. New
WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA(TM) (olaparib) capsules.
- Withering but not falling off, as a blossom that persists on a twig after flowering.